Cachet

What Cachet does

Cachet Pharmaceuticals Private Limited is an Indian pharmaceutical company incorporated in 1978 and operating as a wholly-owned subsidiary of Alkem Laboratories Limited. The company manufactures and markets branded pharmaceutical formulations and nutraceuticals across eight therapy areas: anti-infectives, anti-arthritis, respiratory, gastroenterology, pain management, gynecology, urology, and nutraceuticals. Its underlying technology base consists of two GMP-certified manufacturing facilities — the original unit at Bhiwadi (1987) and a second unit at Baddi (2006) — producing tablets, capsules, injections, syrups, softgels, and oral powders. The portfolio spans 200+ brands, with flagship products including Lysoflam (ranked #1 unit-wise in the Indian pain segment) and Traxol (branded as India's best-selling injectable antibiotic).

The business operates a dual-channel go-to-market model. Domestically, Cachet sells through a network of 350+ stockists and distributors across India, supported by direct sales representatives promoting to doctors and pharmacists. Internationally, the company leverages registered distributors in more than 30 countries across Asia, CIS, Africa, Latin America, and Central America, with regulatory approvals from WHO-GMP and twelve national drug authorities including those of Kenya, Uganda, Ivory Coast, Ethiopia, Ghana, Rwanda, Zambia, Malawi, Yemen, UAE, and Nepal. Revenue is generated through one-time sales of formulations and nutraceuticals, with no disclosed SaaS, licensing, or recurring component.

Cachet reports a workforce of 1,400+ across manufacturing, marketing, and corporate functions, and has historically maintained turnover exceeding INR 400 crores for three consecutive financial years, with an explicit stated ambition to reach INR 1,000 crores. The company is led by Managing Director Mr. Satish Kumar Singh (appointed 2014, 34 years of pharmaceutical industry experience), alongside an Independent Director (Mr. Arunkumar Deshmukh) and two other Directors. Externally, Cachet has received the 2016 European Award for Best Practices (Brussels), International Star for Leadership in Quality Award (Paris), and the Emerging Exporter of the Year Award.

Name

Cachet

Legal name

Cachet Pharmaceuticals Private Limited

Website

https://cachetindia.com

Company type

Private

Founded year

1978

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Cachet Pharmaceuticals Private Limited, an Alkem Laboratories subsidiary founded in 1978, manufactures and markets 200+ branded pharmaceutical formulations and nutraceuticals across anti-infectives, pain management, gastroenterology, and other therapeutic areas for India and 30+ international markets.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Specialty Care Pharmaceuticals (HLAIAAAB)

akta.pro secondary industry

Full-Line Pharmaceutical Wholesalers (HLAIAJAA)

Keywords

• Pharmaceutical manufacturing
• Branded formulations
• Nutraceutical supplements
• Antibiotic medications
• Pain management drugs

Headquarters

HQ city

Worli

HQ country

India

HQ region

Asia

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Pharmaceutical Formulations: Manufacturing and marketing of branded pharmaceutical formulations across multiple therapeutic areas including anti-infectives, pain management, gastroenterology, respiratory, gynecology, urology, and anti-arthritis. Products sold under 200+ brands through domestic and international distribution networks.
2. Nutraceuticals: Manufacturing and marketing of nutraceutical products including vitamins, minerals, antioxidants, and dietary supplements. Products available in multiple formats including tablets, oral powders, hard gel and soft gel capsules, and oral liquids.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

Cachet Pharmaceuticals manufactures and markets branded pharmaceutical formulations (tablets, capsules, injections, syrups, softgels) and nutraceutical products across therapeutic areas including anti-infectives, pain management, gastroenterology, respiratory, gynecology, urology, and anti-arthritis. Operating through two GMP-certified manufacturing facilities, the company sells its 200+ brand portfolio to hospitals, pharmacies, and doctors across India and 30+ international markets via distributor and stockist networks.

Product overview

Cachet Pharmaceuticals Private Limited is a pharmaceutical company manufacturing and marketing a wide range of pharmaceutical formulations and nutraceuticals for domestic and international markets. The company operates under three main product brands: Pharma (acute medications including antibiotics and cold/cough preparations), Life Care (chronic disease management including pain management, nutraceuticals, and specialty medications), and Health Care (gastrointestinal, nutritional supplements, and OTC products). The portfolio includes over 200 brands covering therapeutic areas such as Anti-infectives, Anti-Arthritis, Respiratory, Gastroenterology, Pain Management, Gynecology, Urology, and Nutraceuticals. The company also maintains a dedicated international/derma product line for global markets.

Differentiator

Problem solved

Functional benefit

Brands

• Celza: Brand for pain management products including Celza Tablets
• Cachlite
• Cavit XT
• Fornerve NT
• Geovin
• Hiliv
• Lactoclaav
• Lysoflam
• NE
• Spid Dx
• Traxol
• PNZ

Products and services

• Traxol Antibiotic Injection Range Branded cephalosporin-based antibiotic injections (Ceftriaxone, Ceftriaxone+Sulbactam, Ceftriaxone+Tazobactam, Cefixime) used to treat bacterial infections of the brain, lungs, ear, urinary tract, skin, soft tissues, bones, joints, blood, heart, and to prevent surgical infections; for hospitals, doctors, and pharmacies across India and international markets.
• Lysoflam Pain Management Brand Range Branded pain and inflammation management products including Lysoflam Tablets (Trypsin-Chymotrypsin with Diclofenac Potassium and Paracetamol), Lysoflam-MR (Diclofenac + Metaxalone for muscle spasm pain), and Lysoflam Forte (high-potency Trypsin-Chymotrypsin for post-operative and inflammatory pain); distributed to pharmacies and hospitals through stockists in India and registered distributors internationally.
• PNZ Gastroenterology Brand Range Branded pantoprazole-based gastroenterology products including PNZ 40mg tablets for adults, PNZ 20 MD mouth-dissolving tablets for pediatrics, PNZ D capsules (Pantoprazole + Domperidone) for GERD, and PNZ MPS oral suspension (antacid with Simethicone) for acidity and heartburn relief; sold through hospital and pharmacy channels.
• International Derma and Anti-infective Brand Range Topical and systemic pharmaceutical products for international markets including Instabact Cream (Mupirocin antibacterial), Silvacach Cream (Silver Sulfadiazine + Chlorhexidine burn cream), Cachzole Capsules (Itraconazole antifungal), Cachguard Cream (Luliconazole antifungal), Cachderm-N and Cachderm-G creams (Beclomethasone combinations); for international distributors and healthcare professionals.
• Nutraceuticals and Dietary Supplements Range Nutraceutical products comprising vitamins, minerals, antioxidants, and dietary supplements across multiple formats including NE 400 Sofgels (Natural Vitamin E), NE Forte (L-Carnitine + Ubidecarenone), Cavit XT (pregnancy complications), Fornerve NT (neuropathic pain multivitamin), Cavit Tablets, I UP Suspension (iron and folic acid), Vitzin and Cadbe (multivitamins); sold to pharmacies for consumer health and supplementation.

Quantifiable outcome

• Lysoflam ranked Number 1 unit-wise selling brand in pain segment
• +1 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• International Distributors (30+ Countries)coreChannel Partner/ Reseller/ DistributorCachet has established strategic alliances with local distributors across more than 30 countries covering Asia, CIS, Africa, Latin America, and Central America. These partnerships enable product distribution, contract manufacturing, and strategic marketing initiatives. The company tailors product portfolios to meet diverse healthcare needs of each region.

Scale indicators6 records

Recent moves8 records

Expansion highlights5 records

Broad incumbents

• Cipla: Cipla is a top-5 Indian pharma major with strong emerging-market exports and broad therapeutic coverage including respiratory, anti-infectives, and chronic care. Comparable to Cachet at the therapeutic and channel-overlap level but materially larger and more diversified globally.
• Glenmark Pharmaceuticals: Glenmark has branded generics and specialty portfolio with significant emerging-market presence and India distribution. Comparable in international GTM and therapeutic breadth, though larger and more R&D intensive.
• Alkem Laboratories: Alkem is Cachet's parent company and one of India's largest pharmaceutical companies with a comparable branded generics portfolio spanning anti-infectives, pain, GI, and chronic therapies. It serves as the broadest comparable incumbent given identical therapeutic focus, similar Indian distribution model, and shared manufacturing platform.
• Torrent Pharmaceuticals: Torrent operates a branded generics portfolio across chronic and acute therapies with strong presence in India and emerging markets. Comparable therapeutic coverage and distributor-led model make it a relevant broader incumbent.
• Lupin Limited: Lupin is an Indian major with branded formulations in anti-infectives, pain, GI, and chronic therapy across domestic and emerging markets. Comparable product mix and international regulatory presence make it a relevant incumbent peer despite significantly larger scale.

Direct peers

• Macleods Pharmaceuticals: Macleods is a private Indian pharma company with a similarly broad branded-generics portfolio spanning anti-infectives, pain, GI, and chronic care, distributed domestically via stockists and internationally via emerging-market distributors. Closest direct peer given comparable size, ownership structure, and go-to-market model.
• Mankind Pharma: Mankind is one of India's largest domestic pharma companies by prescription share, with a portfolio of branded generics across antibiotics, pain, GI, and cardiovascular. Highly comparable in therapeutic coverage and the 350+ distributor-led domestic GTM motion.
• Aristo Pharmaceuticals: Aristo is a private Indian pharma company with broad anti-infective, pain, and chronic therapy portfolios distributed domestically and to emerging markets in Africa and Asia. Closely comparable to Cachet on portfolio breadth, ownership structure, and emerging-market focus.
• FDC Limited: FDC is an Indian pharma company with a broad branded-generics portfolio in anti-infectives, GI, and nutrition, distributed domestically and in emerging markets. Comparable in therapeutic coverage and the stockist-driven India GTM model.
• Ipca Laboratories: Ipca manufactures branded formulations across anti-infectives, pain, and chronic therapies with strong African and Asian exports. Comparable to Cachet on therapeutic mix and emerging-market distribution footprint.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/cachetpharma
• Facebookfacebook.com/CachetPharma
• LinkedInlinkedin.com/company/cachet-pharma-alkem-group-

Compliance12 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cachet